BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18054264)

  • 41. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient.
    Kruse AJ; Bottenberg MJ; Tosserams J; Slangen B; van Marion AM; van Trappen PO
    Int J Gynecol Pathol; 2008 Oct; 27(4):591-5. PubMed ID: 18753959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Review of precancerous vulvar lesions].
    Skapa P; Robová H; Rob L; Zámečník J
    Cesk Patol; 2012 Jan; 48(1):15-21. PubMed ID: 22716003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vulvar intraepithelial neoplasia.
    Preti M; Scurry J; Marchitelli CE; Micheletti L
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1051-62. PubMed ID: 25106700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New aspects of vulvar cancer: changes in localization and age of onset.
    Hampl M; Deckers-Figiel S; Hampl JA; Rein D; Bender HG
    Gynecol Oncol; 2008 Jun; 109(3):340-5. PubMed ID: 18407339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.
    Faber MT; Sand FL; Albieri V; Norrild B; Kjaer SK; Verdoodt F
    Int J Cancer; 2017 Sep; 141(6):1161-1169. PubMed ID: 28577297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence: a clinicopathological study of 75 women.
    Regauer S
    Gynecol Oncol; 2011 Nov; 123(2):289-94. PubMed ID: 21802125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma.
    Bleeker MC; Visser PJ; Overbeek LI; van Beurden M; Berkhof J
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1224-30. PubMed ID: 27257093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
    Brustmann H; Brunner A
    Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN).
    Liegl B; Regauer S
    Histopathology; 2006 Feb; 48(3):268-74. PubMed ID: 16430473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Papillomavirus genotyping on formaldehyde fixed paraffin-embedded tissues in vulvar intraepithelial neoplasia.
    Mazellier S; Dadone-Montaudie B; Chevallier A; Loubatier C; Vitale S; Cardot-Leccia N; Angeli K; Trastour C; Delotte J; Giordanengo V; Ambrosetti D
    Arch Gynecol Obstet; 2017 Oct; 296(4):811-817. PubMed ID: 28795241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
    Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of patients with vulvar lichen sclerosus and association to vulvar carcinoma: a retrospective single center analysis.
    Steinkasserer L; Hachenberg J; Hillemanns P; Jentschke M
    Arch Gynecol Obstet; 2023 Jun; 307(6):1921-1928. PubMed ID: 36409332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women.
    Jones RW; Rowan DM; Stewart AW
    Obstet Gynecol; 2005 Dec; 106(6):1319-26. PubMed ID: 16319258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential.
    Hørding U; Junge J; Poulsen H; Lundvall F
    Gynecol Oncol; 1995 Feb; 56(2):276-9. PubMed ID: 7896198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study.
    Jones RW; Sadler L; Grant S; Whineray J; Exeter M; Rowan D
    J Reprod Med; 2004 Oct; 49(10):808-11. PubMed ID: 15568404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Extra-neoplastic epithelial changes in cancer of the vulva].
    Ivanova R; Veselinova T; Marinov E; Gorchev G; Tsetkov Ch; Lalov S
    Akush Ginekol (Sofiia); 1999; 38(4):35-7. PubMed ID: 10726352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Squamous cell carcinoma of the vulva and adjacent lesions treated at Nagoya University Hospital from 1965 to 1997.
    Akashi K; Nagasaka T; Nakashim N; Harada T; Okamoto T; Mizutani S; Ishiko H
    Nagoya J Med Sci; 2001 Nov; 64(3-4):109-21. PubMed ID: 11820332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.